Loading patent…
AssigneeShingotec GmbH
InventorsAndreas Bergmann, Olle Melander
Estimating the term…
Subject matter of the present invention is a method for predicting the risk of getting cancer in a female subject that does not suffer from cancer or alternatively diagnosing cancer in a female subject comprising determining the level of pro-neurotensin or fragments thereof of at least 5 amino acids in a bodily fluid obtained from said female subject; and correlating said level of pro-neurotensin or fragments thereof with the a risk for getting cancer, wherein an elevated level is predictive for an enhanced risk of getting cancer or alternatively diagnosing cancer wherein an elevated level is correlated with the diagnosis of cancer and, wherein said cancer is selected from the group comprising breast cancer, lung cancer, pancreatic cancer and colon cancer.
A method for predicting the risk of getting cancer in a female subject that does not suffer from cancer in a female subject comprising:
A method according to any of the preceding claims, wherein the level of pro-neurotensin 1-117 is determined.
A method according to any of the preceding claims, wherein the level of pro-neurotensin 1-117 or fragments thereof or pro-neurotensin 1-117 comprising peptides is measured with an immunoassay.
A binder to neurotensin or to a neurotensin receptor, for the use in prevention or therapy of cancer in a female subject.
Dependencies are inferred from the claim text.